Mymee

Mymee is a groundbreaking digital care solution that aims to transform autoimmune care by helping patients identify the triggers behind their symptoms. Through their proprietary method, Mymee has been clinically validated to reduce rheumatic flares associated with various autoimmune diseases, including rheumatoid arthritis, lupus, psoriatic arthritis, ankylosing spondylitis, and long COVID with rheumatic symptoms. Their personalized trial care platform, which includes a custom mobile app and weekly analysis sessions with a specialized health coach, empowers patients to regain control of their health by correlating symptoms and triggers, leading to significant improvements in health within an average of 17 weeks.

Mymee's innovative approach has garnered support from industry leaders and has been recognized for its ability to address the challenges faced by at-risk autoimmune patients who are non-responders to standard therapies. By helping patients understand their unique sensitivities to hidden triggers in their environment, Mymee enables them to better manage their autoimmune flares and improve their overall quality of life. With a focus on personalized care and adherence to strict privacy standards, Mymee is revolutionizing autoimmune care and providing hope for those suffering from these debilitating conditions.

Generated from the website